Dr. Tucker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6120 Rockville Pike
Bethesda, MD 20892Phone+1 301-496-4375Fax+1 301-402-4489
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1981 - 1983- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1976 - 1978
Harvard Medical SchoolClass of 1976
Certifications & Licensure
MD State Medical License 1989 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer Start of enrollment: 1985 Apr 02
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma Start of enrollment: 2002 Jul 01
Publications & Presentations
PubMed
- 2 citationsAmbient ultraviolet radiation and ocular melanoma incidence in the United States, 2000-2019.Basilica M Arockiaraj, Elizabeth K Cahoon, Michael R Sargen, Erping Long, Margaret A Tucker
Eye. 2024-06-01 - 3 citationsEstimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.Michael R Sargen, Jung Kim, Thomas P Potjer, Mary E Velthuizen, Arelis E Martir-Negron
JAMA Dermatology. 2023-10-01 - 5 citationsAssociation of germline variants in telomere maintenance genes (and) with spitzoid morphology in familial melanoma: A multi-center case series.Alisa M Goldstein, Richard Qin, Emily Y Chu, David E Elder, Daniela Massi
JAAD International. 2023-06-01
Journal Articles
- ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum ConsortiumMargaret Tucker, MD, Journal of The European Academy of Dermatology and Venereology
Grant Support
- Family StudiesNational Cancer Institute2010–2011
- Applied Molecular Pathology LaboratoryNational Cancer Institute2010–2011
- Family StudiesDivision Of Cancer Epidemiology And Genetics2009
- Family StudiesNational Cancer Institute2007–2008
- Family StudiesDivision Of Cancer Epidemiology And Genetics1997–2006
- LATE Effects Of Cancer TreatmentDivision Of Cancer Epidemiology And Genetics1999–2004
- Neoplasm Epidemiology: Family StudiesDivision Of Cancer Epidemiology And Genetics2001
- LATE EffectsDivision Of Cancer Epidemiology And Genetics1997
- Studies Of Persons At High Risk Of Cancer--Genetic EpidemiologyDivision Of Cancer Epidemiology And Genetics1996
- Studies Of Persons At High Risk Of Cancer--Family StudiesDivision Of Cancer Epidemiology And Genetics1996
- Studies Of Persons At High Risk Of Cancer--Pharmacogenetic StudiesDivision Of Cancer Epidemiology And Genetics1995–1996
- Studies Of Persons At High Risk Of Cancer--Late EffectsDivision Of Cancer Epidemiology And Genetics1995–1996
- Studies Of Persons At High Risk Of Cancer--Genetic EpidemiologyDivision Of Cancer Epidemiology And Genetics1995
- Studies Of Persons At High Risk Of Cancer--Family StudiesDivision Of Cancer Epidemiology And Genetics1995
- Studies Of Persons At High Risk Of CancerDivision Of Cancer Epidemiology And Genetics1986–1994
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
